CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
58 hedge funds and large institutions have $82.9M invested in Crescent Biopharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 6 closing their positions.
Holders
58
Holders Change
+9
Holders Change %
+18.37%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
14
Reduced
13
Closed
6
Calls
$382K
Puts
$69K
Net Calls
+$313K
Net Calls Change
-$45K
Top Buyers
Top Sellers
1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$1.28M |
2 |
2
Renaissance Technologies
New York
|
$294K |
3 |
3
Two Sigma Investments
New York
|
$141K |
4 |
4
Two Sigma Advisers
New York
|
$390K |
5 |
5
Axa
Paris,
France
|
$3.75M |